Delivery Order SPE2DB22D3010-SPE2DB24FP0ZY
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of Dupixent 300 mg/2 ml pens. The $35,657.79 fixed-price delivery order has a completion date of June 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,039.26, is for the delivery of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract is a firm fixed-price delivery order with an ultimate completion date of April 15, 2025. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $57,326.42, is for the delivery of Dupixent 300 mg/2 ml pen injections. It is a firm fixed-price delivery order contract with a completion date of December 13, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Dupixent 200 mg/1.14 ml pen. The contract is a delivery order with a firm fixed price of $14,255.25 and a completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,538.96, is for the delivery of Dupixent 300 mg/2 ml pen injectors. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $47,028.83 Firm Fixed Price delivery order is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $31,119.15, is a delivery order for the supply of Dupixent 300 mg/2 ml pens. The contract has a firm fixed price pricing type and runs through June 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award, valued at $3,010.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml pens. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,657.67 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml pens, with a completion date of November 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,990.40 Firm Fixed Price Delivery Order covers the supply of Dupixent 300 mg/2 ml pens for the DLA's medical support operations. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB22D3010Indefinite Delivery Contract
- SPE2DB22D3010-SPE2DB24FP0ZYDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,513.53, is a Firm Fixed Price Delivery Order for the supply of Dupixent 300 mg/2 ml pen injections. The contract has an ultimate completion date of November 28, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, by supplying a wide array of essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.5k | 11/27/23 |